Literature DB >> 24698423

Renal epithelioid angiomyolipoma with malignant features: Histological evaluation and novel immunohistochemical findings.

Sachiko Konosu-Fukaya1, Yasuhiro Nakamura, Fumiyoshi Fujishima, Atsuko Kasajima, Keely M McNamara, Yayoi Takahashi, Kensuke Joh, Hideo Saito, Naomasa Ioritani, Yoshihiro Ikeda, Yoichi Arai, Mika Watanabe, Hironobu Sasano.   

Abstract

Renal epithelioid angiomyolipoma (EAML) is a potentially malignant tumor type whose characteristics and biomarkers predictive of malignant behavior have not been elucidated. Here, we report three cases of renal EAML with malignant features but without histories of tuberous sclerosis complex. Case 1 involved a 29-year-old man with a 12-cm solid mass in the right kidney who underwent radical right nephrectomy. Case 2 involved a 22-year-old woman with a retroperitoneal mass who underwent radical right nephrectomy and retroperitoneal tumorectomy. Local recurrence was detected 7 years post-surgery. Case 3 involved a 23-year-old man with a 14-cm solid mass in the left kidney who underwent radical left nephrectomy. Microscopically, the tumors in all cases demonstrated proliferation of epithelioid cells with atypia, mitotic activity, necrosis, hemorrhage, and vascular invasion. Epithelioid cells in all cases were immunohistochemically positive for melanocytic and myoid markers and weakly positive for E-cadherin and β-catenin. Immunohistochemistry revealed activation of the mammalian target of rapamycin pathway. Here, we report the morphological and immunohistochemical features of clinically or histologically malignant renal EAML.
© 2014 The Authors. Pathology International © 2014 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  E-cadherin; epithelioid angiomyolipoma; mTOR; malignant angiomyolipoma; β-catenin

Mesh:

Substances:

Year:  2014        PMID: 24698423     DOI: 10.1111/pin.12142

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

Review 1.  Clinicopathologic features of renal epithelioid angiomyolipoma: report of one case and review of literatures.

Authors:  Guobin Tan; Lei Liu; Mingning Qiu; Lieqian Chen; Jun Cao; Jianjun Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Ruptured hepatic epithelioid angiomyolipoma: a case report and literature review.

Authors:  Shogo Tajima; Akira Suzuki; Kiyoshi Suzumura
Journal:  Case Rep Oncol       Date:  2014-05-29

3.  Malignant renal epithelioid angiomyolipoma: A case report and review of the literature.

Authors:  Baoyin Guo; Hualin Song; Jiuling Yue; Gang Li
Journal:  Oncol Lett       Date:  2015-10-30       Impact factor: 2.967

4.  Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study.

Authors:  Xin-Gang Bi; Lei Guo; Xiao-Liang Wang; Qian Wei; Qiang Du; Wen-Hao Jiang; Guang-Yuan Zheng; Hong-Tu Zhang; Jian-Hui Ma; Shan Zheng
Journal:  Oncol Lett       Date:  2017-05-29       Impact factor: 2.967

5.  Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target

Authors:  Oren Pleniceanu; Racheli Shukrun; Dorit Omer; Einav Vax; Itamar Kanter; Klaudyna Dziedzic; Naomi Pode-Shakked; Michal Mark-Daniei; Sara Pri-Chen; Yehudit Gnatek; Hadas Alfandary; Nira Varda-Bloom; Dekel D Bar-Lev; Naomi Bollag; Rachel Shtainfeld; Leah Armon; Achia Urbach; Tomer Kalisky; Arnon Nagler; Orit Harari-Steinberg; Jack L Arbiser; Benjamin Dekel
Journal:  EMBO Mol Med       Date:  2017-04       Impact factor: 12.137

6.  Primary kidney malignant epithelioid angiomyolipoma: Two cases report and review of literature.

Authors:  Rui Zhan; Yan-Qing Li; Chun-Yan Chen; Han-Yu Hu; Chun Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

7.  A novel 8.57-kb deletion of the upstream region of PRKAR1A in a family with Carney complex.

Authors:  Shin Ito; Aya Hashimoto; Kazunori Yamaguchi; Sadafumi Kawamura; Shingo Myoen; Maki Ogawa; Ikuro Sato; Takamichi Minato; Shingo Miyabe; Akira Nakazato; Keitaro Fujii; Mai Mochizuki; Haruna Fujimori; Keiichi Tamai; Tetsuya Niihori; Yoko Aoki; Akira Sugawara; Hironobu Sasano; Hiroshi Shima; Jun Yasuda
Journal:  Mol Genet Genomic Med       Date:  2022-02-06       Impact factor: 2.183

8.  mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma.

Authors:  Oren Pleniceanu; Dorit Omer; Einat Azaria; Orit Harari-Steinberg; Benjamin Dekel
Journal:  Kidney Int Rep       Date:  2017-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.